Also known as:
AML with 11q23 abnormalities, AML with t(9;11)(p22;q23); MLLT3-MLL, acute myeloid Leukaemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A, acute myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A, acute myeloid leukaemia with 11q23 (MLL) abnormalities, acute myeloid leukaemia with MLL abnormalities, acute myeloid leukaemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A, acute myeloid leukaemia with t(9;11)(p22;q23); MLLT3-MLL, acute myeloid leukemia with 11q23 (MLL) abnormalities, acute myeloid leukemia with MLL abnormalities, acute myeloid leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A, acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL
Also known as:
AML with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22), AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22), CBFB-MYH11, acute myelomonocytic leukaemia, acute myelomonocytic leukemia
Also known as:
AML with BCR-ABL1, AML with t(9;22)(q34.1;q11.2), acute myeloid leukaemia with t(9;22)(q34.1;q11.2), acute myeloid leukemia with t(9;22)(q34.1;q11.2)
Also known as:
AML with CEBPA somatic mutations, AML with mutated CEBPA, acute myeloid Leukaemia with mutated CEBPA, acute myeloid Leukaemia with non-germline mutated CEBPA, acute myeloid Leukemia with mutated CEBPA, acute myeloid Leukemia with non-germline mutated CEBPA, non-familial acute myeloid leukaemia with mutated CEBPA, non-familial acute myeloid leukemia with mutated CEBPA
Also known as:
AML with inv3(p21;q26.2) or t(3;3)(p21;q26.2), AML with inv3(q21;q26.2) or t(3;3)(q21;q26.2), acute myeloid leukaemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2), acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2)
Also known as:
AML M0, AML with minimal differentiation, AMLMD, M0 acute granulocytic leukaemia, M0 acute granulocytic leukaemia with minimal differentiation, M0 acute granulocytic leukemia, M0 acute granulocytic leukemia with minimal differentiation, M0 acute myeloblastic leukaemia, M0 acute myeloblastic leukemia, M0 acute myelocytic leukaemia, M0 acute myelocytic leukemia, M0 acute myelogenous leukaemia, M0 acute myelogenous leukaemia with minimal differentiation, M0 acute myelogenous leukemia, M0 acute myelogenous leukemia with minimal differentiation, M0 myeloid leukaemia, M0 myeloid leukaemia with minimal differentiation, M0 myeloid leukemia, M0 myeloid leukemia with minimal differentiation, acute myeloblastic leukaemia with minimal differentiation, acute myeloblastic leukemia with minimal differentiation, acute myeloblastic leukemia, minimally differentiated, acute myelocytic leukaemia with minimal differentiation, acute myelocytic leukemia with minimal differentiation, acute myelogenous leukaemia with minimal differentiation, acute myelogenous leukemia with minimal differentiation, acute myeloid leukaemia with minimal differentiation (MO), acute myeloid leukemia with minimal differentiation, acute myeloid leukemia with minimal differentiation (MO), acute myeloid leukemia, minimally differentiated, minimally differentiated acute myeloblastic leukaemia, minimally differentiated acute myeloblastic leukemia
Also known as:
AML with multilineage dysplasia, AML with myelodysplasia-related features, De novo acute myeloid leukaemia with multilineage dysplasia, De novo acute myeloid leukemia with multilineage dysplasia, acute myeloid leukaemia with myelodysplasia-related features, acute myeloid leukemia with myelodysplasia-related features
Also known as:
AML with mutated NPM1, AML, Mutation of the Nucleophosmin Gene, AML, NPM1 Mutation, AML, NPM1 gene mutation, AML, Nucleophosmin Gene Mutation, NPMc+ AML, acute myeloid leukaemia with cytoplasmic nucleophosmin, acute myeloid leukemia with cytoplasmic nucleophosmin, acute myeloid leukemia with mutated NPM1, acute myeloid leukemia, NPM1 gene mutation
Also known as:
AML with NPM1 somatic mutations
Also known as:
AML with t(6;9)(p23;q34)
